研究项目库 / NCT02978625

Biopsy Procedure用于淋巴瘤的II 期研究

这是一项关于淋巴瘤的II 期研究,登记的药物或干预包括Biopsy Procedure;Biospecimen Collection;Computed Tomography;Laboratory Biomarker Analysis;Nivolumab;Positron Emission Mammography;Talimogene,当前状态为研究进行中,已停止招募。登记地点显示中国Los Angeles、Orange、Pasadena、Sacramento等城市有研究中心记录。是否仍有名额以及是否值得进一步询问,需要向研究中心确认。

一分钟看懂

这是一项关于淋巴瘤的II 期研究,登记的药物或干预包括Biopsy Procedure;Biospecimen Collection;Computed Tomography;Laboratory Biomarker Analysis;Nivolumab;Positron Emission Mammography;Talimogene,当前状态为研究进行中,已停止招募。登记地点显示中国Los Angeles、Orange、Pasadena、Sacramento等城市有研究中心记录。是否仍有名额以及是否值得进一步询问,需要向研究中心确认。

药物或干预

Biopsy Procedure;Biospecimen Collection;Computed Tomography;Laboratory Biomarker Analysis;Nivolumab;Positron Emission Mammography;Talimogene Laherparepvec · II 期

登记条件中文摘要

年龄范围:18岁及以上

登记的基本范围为不限性别,年龄18岁及以上;以下仅摘录8项专业入选条件,需结合英文原文并由研究团队确认。

登记记录列出8项主要排除条件,具体医学含义需结合英文原文并由研究团队确认。

中国哪些地方有记录

以下地点来自登记信息,不代表此刻仍有名额;请向研究中心确认最新情况。

  • Los Angeles General Medical Center · Los Angeles
  • USC / Norris Comprehensive Cancer Center · Los Angeles
  • UC Irvine Health/Chao Family Comprehensive Cancer Center · Orange
  • Keck Medical Center of USC Pasadena · Pasadena
  • University of California Davis Comprehensive Cancer Center · Sacramento
  • UCHealth University of Colorado Hospital · Aurora
  • UM Sylvester Comprehensive Cancer Center at Aventura · Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables · Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach · Deerfield Beach
  • University of Miami Miller School of Medicine-Sylvester Cancer Center · Miami
  • UM Sylvester Comprehensive Cancer Center at Kendall · Miami
  • UM Sylvester Comprehensive Cancer Center at Plantation · Plantation
  • Northwestern University · Chicago
  • University of Kansas Clinical Research Center · Fairway
  • University of Kansas Cancer Center-Overland Park · Overland Park
  • University of Kansas Hospital-Indian Creek Campus · Overland Park
  • University of Kansas Hospital-Westwood Cancer Center · Westwood
  • Johns Hopkins University/Sidney Kimmel Cancer Center · Baltimore
  • Massachusetts General Hospital Cancer Center · Boston
  • Dana-Farber Cancer Institute · Boston
  • Siteman Cancer Center at Saint Peters Hospital · City of Saint Peters
  • Siteman Cancer Center at West County Hospital · Creve Coeur
  • University of Kansas Cancer Center - North · Kansas City
  • University of Kansas Cancer Center - Lee's Summit · Lee's Summit
  • University of Kansas Cancer Center at North Kansas City Hospital · North Kansas City
  • Washington University School of Medicine · St Louis
  • Siteman Cancer Center-South County · St Louis
  • University of Nebraska Medical Center · Omaha
  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · Lebanon
  • Rutgers Cancer Institute of New Jersey · New Brunswick

入选条件原文摘录

以下为摘录,请打开原始登记查看完整入排标准。

  • * Patients must have histologic or cytologic diagnosis of non-melanoma skin cancer (NMSC) or lymphomas other than B-cell lymphomas; as both of those terms are categories rather than specific diagnoses, specific guidance on eligible tumor types is provided below
  • * PART I (before February 2020 amendment): Included tumor types
  • T cell and NK cell lymphomas, including, but not limited to: cutaneous T-cell lymphomas (CTCL), mycosis fungoides (MF), Sezary syndrome (SS), peripheral T-cell lymphoma (PTCL), ALK-positive and ALK-negative anaplastic large cell lymphoma (ALCL), and NK-cell lymphomas
  • Merkel cell carcinoma
  • Squamous cell carcinoma of the skin, including keratoacanthomas, vulvar squamous carcinoma, and mixed histology tumors, such as basosquamous carcinoma, and squamous cell carcinoma of unknown primary consistent with skin origin
  • Other non-melanoma skin cancers
  • Basal cell carcinoma
  • Malignant sweat gland tumors, including porocarcinoma, hidradenocarcinoma, spiradenocarcinoma, cylindrocarcinoma, microcystic adnexal carcinoma and related entities, squamoid eccrine ductal carcinoma, cutaneous adenoid cystic carcinoma, digital papillary adenocarcinoma, primary cutaneous mucinous carcinoma, endocrine mucin-producing sweat gland carcinoma, primary cutaneous signet ring cell carcinoma, cutaneous apocrine gland carcinoma, and extraocular sebaceous carcinoma

联系前需要确认

请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。

查看登记信息

登记号:NCT02978625;登记信息更新于 2026-08-13;本站同步于 2026-10-08。

查看原始登记记录